• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑素细胞病变中的 HLA 抗原表达:获得 HLA 抗原表达是否是不典型(发育不良)黑素细胞的生物标志物?

HLA antigen expression in melanocytic lesions: is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?

机构信息

Department of Dermatology, University of Colorado, Denver (Health Sciences Center), Aurora, Colorado, USA.

出版信息

J Am Acad Dermatol. 2012 Jun;66(6):911-6, 916.e1-8. doi: 10.1016/j.jaad.2011.04.025. Epub 2012 Mar 23.

DOI:10.1016/j.jaad.2011.04.025
PMID:22445792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8559555/
Abstract

BACKGROUND

Although criteria are established for the histologic diagnosis of atypical nevi (AN), consensus about the criteria in the diagnosis of and in the definition of AN is limited. Moreover, intraobserver and interobserver differences in the application of these criteria for the diagnosis of AN have been observed.

OBJECTIVE

We sought to determine the usefulness of HLA antigen expression as a biomarker of AN.

METHODS

The immunoperoxidase reaction was used to mark common nevi and AN with HLA class I heavy chain-, β2microglobulin (β2m)-, and HLA class II β chain-specific monoclonal antibodies.

RESULTS

HLA class I heavy chain, β2m, and HLA class II β chain were expressed in 5 (8.6%) of the 58 common nevi and in 46 (∼72%) of the 64 atypical melanocytic lesions. Among common lesions, only halo nevi expressed HLA class I heavy chain, β2m, and HLA class II β chain. The level of HLA class I heavy chain β2m and of HLA class II β chain expression correlated with the degree of cytologic atypia and architectural disorder.

LIMITATIONS

The number of lesions tested and the subjective nature of the analysis of immunohistochemical staining of tissue sections are both limitations.

CONCLUSIONS

The data presented suggest that HLA antigen expression is an objective biomarker that correlates well with the degree of cytologic atypia in AN and may: (1) be useful to distinguish common nevi from AN, and (2) represent a more objective measure to determine which AN should be excised.

摘要

背景

虽然已经为非典型痣(AN)的组织学诊断制定了标准,但在诊断和定义 AN 方面对这些标准的共识有限。此外,在应用这些标准诊断 AN 时,观察者内和观察者间的差异已经被观察到。

目的

我们试图确定 HLA 抗原表达作为 AN 生物标志物的有用性。

方法

使用免疫过氧化物酶反应标记常见痣和 AN,使用 HLA Ⅰ类重链、β2 微球蛋白(β2m)和 HLA Ⅱ类β 链特异性单克隆抗体。

结果

在 58 个常见痣中的 5 个(8.6%)和 64 个非典型黑素细胞病变中的 46 个(约 72%)中表达了 HLA Ⅰ类重链、β2m 和 HLA Ⅱ类β 链。在常见病变中,只有 halo nevus 表达了 HLA Ⅰ类重链、β2m 和 HLA Ⅱ类β 链。HLA Ⅰ类重链、β2m 和 HLA Ⅱ类β 链的表达水平与细胞异型性和结构紊乱的程度相关。

局限性

测试的病变数量和组织切片免疫组织化学染色分析的主观性都是限制因素。

结论

所提供的数据表明,HLA 抗原表达是一种客观的生物标志物,与 AN 的细胞异型性程度密切相关,并且可能:(1)有助于区分常见痣和 AN;(2)代表一种更客观的方法来确定哪些 AN 应该切除。

相似文献

1
HLA antigen expression in melanocytic lesions: is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?黑素细胞病变中的 HLA 抗原表达:获得 HLA 抗原表达是否是不典型(发育不良)黑素细胞的生物标志物?
J Am Acad Dermatol. 2012 Jun;66(6):911-6, 916.e1-8. doi: 10.1016/j.jaad.2011.04.025. Epub 2012 Mar 23.
2
Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.用针对HLA抗原不同单态决定簇的单克隆抗体对恶性黑色素瘤和痣细胞痣进行免疫组织化学分析。
Cancer Res. 1984 Sep;44(9):3930-5.
3
Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi.晕痣中主要组织相容性抗原及单核细胞浸润的分析
J Invest Dermatol. 1985 Jul;85(1):25-9. doi: 10.1111/1523-1747.ep12274521.
4
Beta 2 microglobulin expression in normal melanocytes, nevocellular nevi, and malignant melanomas.β2微球蛋白在正常黑素细胞、痣细胞痣和恶性黑色素瘤中的表达。
J Invest Dermatol. 1989 May;92(5 Suppl):243S-247S. doi: 10.1111/1523-1747.ep13075770.
5
Architectural features in melanocytic lesions with cellular atypia.具有细胞异型性的黑素细胞性病变中的结构特征。
Dermatologica. 1988;177(3):129-37. doi: 10.1159/000248530.
6
Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.对良性和恶性黑素细胞性病变中HLA抗原表达的分析表明,HLA-G表达上调与恶性转化、高炎症浸润和HLA-A1基因型相关。
Int J Cancer. 2004 Jan 10;108(2):243-50. doi: 10.1002/ijc.11456.
7
Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi.私人病理诊所中的黑素细胞性病变。不同肿瘤类型组织学特征的比较,特别提及发育异常痣。
APMIS. 1993 Nov;101(11):845-50. doi: 10.1111/j.1699-0463.1993.tb00190.x.
8
Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis.发育异常痣中的黑素细胞异型性。免疫组织化学和细胞光度分析。
Cancer. 1988 Apr 15;61(8):1660-6. doi: 10.1002/1097-0142(19880415)61:8<1660::aid-cncr2820610825>3.0.co;2-x.
9
WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.WT1和Bcl2在结膜黑素细胞病变中的表达:123例免疫组织化学研究
Arch Ophthalmol. 2009 Aug;127(8):964-9. doi: 10.1001/archophthalmol.2009.183.
10
Correlating architectural disorder and cytologic atypia in Clark (dysplastic) melanocytic nevi.克拉克(发育异常)黑素细胞痣中结构紊乱与细胞学非典型性的相关性。
Hum Pathol. 1999 May;30(5):500-5. doi: 10.1016/s0046-8177(99)90191-0.

引用本文的文献

1
Introduction: MHC/KIR and governance of specificity.引言:主要组织相容性复合体/杀伤细胞免疫球蛋白样受体与特异性调控
Immunogenetics. 2017 Aug;69(8-9):481-488. doi: 10.1007/s00251-017-0986-6. Epub 2017 Jul 10.
2
Oncogene-Expressing Senescent Melanocytes Up-Regulate MHC Class II, a Candidate Melanoma Suppressor Function.表达癌基因的衰老黑素细胞上调II类主要组织相容性复合体,一种潜在的黑色素瘤抑制功能。
J Invest Dermatol. 2017 Oct;137(10):2197-2207. doi: 10.1016/j.jid.2017.05.030. Epub 2017 Jun 22.
3
Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanoma.

本文引用的文献

1
The "dysplastic" nevus.“发育异常性”痣。
Clin Dermatol. 2009 Jan-Feb;27(1):103-15. doi: 10.1016/j.clindermatol.2008.09.008.
2
The limited specificity of histological examination in the diagnosis of dysplastic nevi.组织学检查在发育异常痣诊断中的特异性有限。
J Cutan Pathol. 2008 Nov;35 Suppl 2:20-3. doi: 10.1111/j.1600-0560.2008.01131.x.
3
Dysplastic nevus: the eye of the hurricane.发育异常痣:飓风之眼。
γ-干扰素诱导的溶酶体巯基还原酶在人类黑色素瘤中上调。
Melanoma Res. 2016 Apr;26(2):125-37. doi: 10.1097/CMR.0000000000000230.
4
[Dysplastic melanocytic nevus].[发育异常性黑素细胞痣]
Pathologe. 2015 Feb;36(1):46-50, 52. doi: 10.1007/s00292-014-2061-5.
5
Genome-wide analysis of gene and protein expression of dysplastic naevus cells.发育异常痣细胞的基因和蛋白质表达的全基因组分析。
J Skin Cancer. 2012;2012:981308. doi: 10.1155/2012/981308. Epub 2012 Nov 28.
6
HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition.恶性细胞中 HLA 抗原和 NK 细胞激活配体的表达:一个关于丢失或获得的故事。
Semin Immunopathol. 2011 Jul;33(4):321-34. doi: 10.1007/s00281-011-0270-z. Epub 2011 Apr 28.
J Cutan Pathol. 2008 Nov;35 Suppl 2:16-9. doi: 10.1111/j.1600-0560.2008.01142.x.
4
Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting.临床环境中疑难黑素细胞肿瘤组织病理学诊断的不一致性。
J Cutan Pathol. 2008 Apr;35(4):349-52. doi: 10.1111/j.1600-0560.2007.00970.x.
5
Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma.具有中度至重度组织学发育异常的发育异常痣:黑色素瘤的一个危险因素。
Br J Dermatol. 2006 Nov;155(5):988-93. doi: 10.1111/j.1365-2133.2006.07466.x.
6
Reporting recommendations for tumor marker prognostic studies (REMARK).肿瘤标志物预后研究报告建议(REMARK)。
J Natl Cancer Inst. 2005 Aug 17;97(16):1180-4. doi: 10.1093/jnci/dji237.
7
Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.手术切除的黑色素瘤病灶中选择性单态性和多态性HLA I类抗原决定簇缺失
Tissue Antigens. 2005 May;65(5):419-28. doi: 10.1111/j.1399-0039.2005.00381.x.
8
Classical and nonclassical HLA class I antigen and NK Cell-activating ligand changes in malignant cells: current challenges and future directions.恶性细胞中经典和非经典HLA I类抗原及自然杀伤细胞激活配体的变化:当前挑战与未来方向
Adv Cancer Res. 2005;93:189-234. doi: 10.1016/S0065-230X(05)93006-6.
9
Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide.单克隆抗体HC-10特异性肽对β2-微球蛋白缺失的HLA I类重链的表位模拟
J Immunol. 2003 Aug 15;171(4):1918-26. doi: 10.4049/jimmunol.171.4.1918.
10
Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology.发育异常痣的管理:美国皮肤科协会会员调查
J Am Acad Dermatol. 2002 May;46(5):674-82. doi: 10.1067/mjd.2002.121029.